Progress on the road to reform at the FDA
This article was originally published in Clinica
In 1999, the US FDA continued to reorganise many of its activities And further implemented provisions of the 1997 FDA Modernization Act (FDAMA). It also provided a clear signal that it will take action in court to force companies to comply with its quality system regulation (QSR). Jonathan Kahan and Ted Wilson review the year's major developments.